Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
Not yet recruiting · NCT06998095 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Not yet recruiting | Not stated | 2026-06-04 | NCT06998095 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||